GSK plc (LSE/NYSE: GSK) and ViiV Healthcare, the global specialist HIV company majority-owned by GSK with Shionogi as a shareholder, have announced headline findings from the phase IIIb CROWN study confirming that long-acting Cabenuva(cabotegravir + rilpivirine )...
The School of Pharmacy, School of Allied Health, and Department of Hospital Management, Bhawanipur Global Campus, Kolkata, successfully organized the 16th...